Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol

Thromb Haemost. 1998 Jul;80(1):109-13.

Abstract

This study establishes a population PK model for FVII clotting activity (FVII:C) after injection of recombinant activated factor VII (rFVIIa) to healthy volunteers. Twenty eight volunteers, anticoagulated with acenocoumarol, received one or two rFVIIa injections, with dose ranging from 5 to 320 microg/kg. The FVII:C kinetic was fitted to a 2 compartment model, with continuous "endogenous perfusion" mimicking endogenous activity. Estimated clearance was 2.4 1/h (20% inter-individual variability and 9% inter-period variability). The volume of distribution at steady-state appeared to be significantly dose dependent: 78 ml/kg for doses < or = 20 microg/kg and 88 ml/kg for doses > 20 microg/kg respectively, with 16% inter-individual variability. The dose producing 50% of the maximum drop of INR was estimated to be 2.2 microg/kg. The model will be used to better define the dosage regimen for future clinical developments.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acenocoumarol / therapeutic use*
  • Anticoagulants / therapeutic use*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Interactions
  • Factor VIIa / pharmacokinetics*
  • Humans
  • Logistic Models
  • Recombinant Proteins / pharmacokinetics
  • Reference Values

Substances

  • Anticoagulants
  • Recombinant Proteins
  • Factor VIIa
  • Acenocoumarol